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ABSTRACT 
 
Background 
Serum γ-glutamytransferase (GGT) and obesity have been regarded as risk factors for type 
2 diabetes. Some observational studies have shown that the association of obesity with the risk 
of type 2 diabetes according to serum GGT is either weakened or strengthened. However, the 
evidence of the interaction between GGT and obesity on the risk of diabetes is insufficient, 
and the association between visceral adiposity and diabetes according to serum GGT has not 
been examined.   
 
Purpose 
  We examined the association between various parameters of obesity and the risk of 
prevalence of diabetes in accordance with serum GGT and analyzed the interaction between 
visceral adiposity and GGT on the risk of prevalence of diabetes in cross-sectional study.. 
 
Methods 
There were 2,948 participants, aged 40 to 70 years from Korean Rural Genomic Cohort 
(KRGC). The participants received at least one medical examination and completed a 
questionnaire during 2005-2006. We examined the risk of prevalence of diabetes according to 
quartiles of waist circumference (WC), visceral fat area (VFA) and serum GGT, respectively. 
We determined the combined effect of variables and the interaction between WC or VFA and 
GGT on the risk of diabetes.  
 
 v
Results 
  Adjusted odds ratios (ORs) for prevalence of diabetes showed an increased response to 
successive quartiles of WC, VFA, and GGT. Area under the curves for WC, VFA and GGT 
associated with prevalence of diabetes were similar, respectively. Adjusted ORs for the strata 
defined by pairs of variables were increased (ORs = 2.01, 2.68, 3.88 for GGT and VFA; ORs = 
2.24, 2.82, 4.17 for GGT and WC). The risk of WC or VFA on prevalence of diabetes was not 
associated within the lower quartiles of GGT. However, risk of prevalence of diabetes was 
increased according to quartiles of GGT in all categories of WC or VFA. The interaction 
between WC or VFA and GGT on the risk of prevalence of diabetes was not statistically 
significant (p value=0.22 and 0.34). 
   
Conclusion 
  Our findings revealed a combined effect of WC or VFA and serum GGT on the risk of 
prevalence of diabetes. These results indicate that serum GGT may be a more influential factor 
than abdominal obesity or visceral fat on the risk of prevalence of diabetes.  
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INTRODUCTION
Traditionally, serum Ȗ-glutamytransferase (GGT) has been regarded as a biomarker of alcohol 
consumption or liver disease (Brenner et al, 1997). However, different epidemiological studies have 
shown an association between serum GGT activity and many cardiovascular risk factors or metabolic 
components, even when serum GGT level is within the reference range (Nilssen et al, 1990; Brenneret al, 
1997). In addition, prospective observational studies have shown that serum GGT activity predicts 
development of cardiovascular disease (CVD) (Wannamethee et al, 1995; Ruttmann et al, 2005), 
hypertension (Miura et al, 1998; Lee et al, 2003), stroke (Jousilahti et al, 2000), and type 2 diabetes (Perry 
et al, 1998; Lee et al, 2003; Lee et al, 2004). 
Although serum GGT is used as a biomarker for hepatic damage, cellular GGT is a membrane binding 
enzyme responsible for the extracelluar catabolism of glutathione to synthesize intracellular glutathione 
(Pompella et al, 2004). Thus, GGT plays an important role in antioxidant systems with the primary 
function of maintaining intracellular concentration of glutathione (Forman et al, 1997). GGT levels 
correlate positively with C-reactive protein (CRP), a marker of inflammation, and F2-isoprostanes, a 
marker of oxidative stress (Lee et al, 2003). GGT levels also correlate inversely with antioxidant levels, 
such as serum carotenoids and tocopherols (Lee et al, 2004). 
Obesity is a common disorder in many industrialized countries (Conway et al, 2004). Obesity is 
thought to be an important risk factor for type 2 diabetes (Mensah et al, 2004). The obese population with 
abdominal obesity is more frequently associated with the development of CVD, hypertension, and 
diabetes compared to obese people with non-abdominal obesity. 
Some prospective studies have shown that the association of obesity with risk of type 2 diabetes may 
be weak in people with low normal serum GGT (Lee et al, 2003; Lee et al, 2004). Recently, in a study 
designed to investigate the possible interaction between GGT and obesity on the risk of type 2 diabetes, 
the association between obesity and prevalence of diabetes became clear with increasing GGT. In this 
study, the authors suggested that obesity itself may not be a sufficient risk factor for type 2 diabetes (Lim 
et al, 2007). Despite of these findings, the evidence of the interaction between GGT and obesity in 
predicting type 2 diabetes is not sufficient. Moreover, in comparison with obesity, it is known that visceral 
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fat distribution is more strongly associated with a risk for diabetes, hypertension, and metabolic syndrome. 
However, the study concerning the association between visceral adiposity and type 2 diabetes according 
to serum GGT activity has not been performed.  
Therefore, to identify the relation among serum GGT, abdominal obesity and type 2 diabetes and to 
examine the interaction between these factors, we investigated that the association of abdominal obesity 
with type 2 diabetes according to different GGT activities. We examined visceral fat area (VFA) to 
estimate visceral adiposity and to more accurately assess risk of abdominal obesity for diabetes. In 
addition, we also analyzed that the interaction between VFA and serum GGT on the risk of type 2 diabetes. 
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METHOD
Study Population 
The Korean Rural Genomic Cohort (KRGC) is a prospective cohort that was designed to assess risk 
factors for mortality, morbidity, incidence of various chronic diseases such as diabetes mellitus, 
hypertension and cardiovascular disease. The KRGC study was also designed to ascertain genomic 
characteristics for metabolic syndrome, atherosclerosis and different cancers in Korean people.  
The KRGC includes 10,111 Koreans and is composed of participants who were 40 to 70 year old 
healthy prople, living in 5 rural areas (Won-ju, Pyung-chang, Keum-san, Na-ju, and Kang-reung). The 
data were collected in 2005 and 2006. Of these geographical areas, we chose 5,178 participants from 2 
areas (3,181 in Won-ju and 1,997 in Pyung-chang). The participants received at least one medical 
examination and completed a questionnaire during that period. The current analysis was limited to 3,241 
participants whose body compositions were analyzed by bioelectrical impedance analysis (BIA). The 293 
participants who had reported a history of any liver disease such as acute or chronic hepatitis, fatty liver 
and liver cirrhosis were excluded. Additionally, participants with missing data on any covariate 
information were also excluded from this study. Finally, 2,948 participants (1,168 men and 1,780 women) 
were included in the final analyses. (Figure 1.)  
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Figure 1.  The selection procedure of the study population  
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Data Collection
The medical examinations were performed according to a standard procedure and conducted by 
trained medical staffs. Participants were questioned about their health behaviors including history of 
smoking, alcohol consumption, and exercise status. Participants were also asked if they were currently 
being treated for any diseases. If so, they were asked for the date of diagnosis and a list of medications 
being taken. The completed questionnaires were reviewed by a trained staff and then entered into a 
database. The data were also checked again during the analysis. Smoking history was categorized as 
“non-smoker”, “ex-smoker” and “current smoker”. Alcohol consumption was categorized as “non-
drinker”, “ex-drinker” and “current drinker”. Exercise status was determined by a description of regular 
sweating. Body mass index (BMI, kg/m2) was calculated as the ratio of weight (kilograms) divided by 
height squared (meters2). Waist circumference (WC) was measured at the mid-point between the lower 
border of the rib cage and the iliac crest.  
After a 12-h overnight fast, blood samples were taken from the antecubital vein of the participants. 
Various biochemical markers, including fasting plasma glucose, total cholesterol, triglyceride, high 
density lipoprotein (HDL) –cholesterol, aspartate aminotransferase (AST), alanine aminotransferase 
(ALT), Ȗ-glutamyltransferase (GGT) (ADVIA 1650, Bayer, USA), and fasting insulin (Insulin RIA Kit, 
Biosource, Belgium) were measured. Diabetes was defined when a subject had a past history of the 
disorder, a medication history of diabetes or a fasting plasma glucose level ˻126mg/dL.  
Medical data collection of the study was processed after obtaining consent from participants. The 
study was approved by Institutional Review Boards of Yonsei University Wonju College of Medicine.  
VFA measurement 
Bioelectrical impedance analysis is a widely used method for estimating body composition. This 
method is relatively simple, safe, noninvasive and convenient for the patient, and has been used in diverse 
settings, including private clinician’s office, health promotion center, and hospital (NIH, 1996). Proper 
detector electrode placement is essential for accurate and reproducible BIA measurement. For this study, 
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the electrodes were positioned on both hands, just proximal to the metacarpal phalangeal joint line, and 
on both feet, without socks, just proximal to the metatarsal phalangeal joint line. Participants were in the 
standing position. Body composition such as body fat and VFA were analyzed automatically by BIA (Jeus 
9.9, JAWON Medical, Korea). A preliminary study was done to assess validity and reliability of VFA 
measured by BIA. In that study of 50 people intra-abdominal VFA was measured using a CT scan at the 
level of the umbilicus (approximately the level of L4 and L5) in accordance with a method previously 
reported (Van der Kooy et al, 1993). The Hounsfield units of adipose tissue areas were in the range of -
250 to -50. The results bshowed that correlation between VFA quantified by CT and VFA analyzed by 
BIA was comparable (r=0.94, p value <0.01).   
Statistical Analysis 
Chi-square test and one-way analysis of variance were used to analyze statistical differences among 
characteristics of the study participants according to GGT levels. Categorization of GGT levels into 
quartiles was based on the distribution of GGT levels among the study participants aged 40 to 70 years. 
Therefore, in the total population, GGT levels (IU/L) were categorized as follows: Q1 <13, Q2 13-18.9, 
Q3 19-32.9, and Q4 ˻33. According to gender, GGT levels were categorized as follows in men: Q1 <20, 
Q2 20-30.9, Q3 31-56.9, and Q4 ˻57, in women: Q1 <11, Q2 11-14.9, Q3 15-21.9, and Q4 ˻22.    
Multiple logistic regression was performed to examine the association between WC, VFA, or serum 
GGT and prevalence of diabetes after adjusting for age, sex, cigarette smoking, alcohol consumption, 
exercise, systolic blood pressure, and total cholesterol. Area under the curves of GGT, VFA and WC 
associated with an increase in the prevalence of diabetes were calculated using the receiver operating 
characteristics (ROC) curve. We used multiple logistic analysis to determine the interactive association 
between BMI, or WC and VFA as the variables for estimating abdominal obesity and visceral adiposity, 
and prevalent diabetes after adjusting for age, sex, cigarette smoking, alcohol consumption, exercise, 
systolic blood pressure, and total cholesterol. 
All analyses were conducted using SAS statistical software, version 8.1 (SAS Institute Inc, Cary, NC). 
All statistical tests were two-sided, and statistical significance was determined at p value<0.05. (Figure 
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All statistical tests were two-sided, and statistical significance was determined at p value<0.05. (Figure 
2.) 
Independent variables
Prevalence of type 2 DM
WC
VFA levels (quartiles)
BMI
Dependent variables
GGT levels (quartiles)
Confounding variables
Age, Sex, Cigarette smoking,
Alcohol drinking,
Exercise, Blood pressure,
Total cholesterol
Independent variables
Logistic 
regression
ȱ2 test
ANOVA
Figure 2.  The framework of the study 
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RESULTS 
The general characteristics of the study population according to quartiles of serum GGT for each 
gender are shown in Tables 1, 2 and 3. The mean BMI, waist circumference, systolic and diastolic blood 
pressure, total cholesterol, TG, AST, ALT, fasting plasma glucose, and VFA increased with higher serum 
GGT activity. Higher serum GGT activity for both genders was found according to the percentages as 
current smokers and current drinkers. The percentages of non-smoker and non-drinker had inverse 
relation with serum GGT inactivity inversely associated with serum GGT activity. Exercise status was not 
significantly associated with serum GGT activity. 
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Table 1. General characteristics of participants 
Characteristics
Male
(n=1168) 
Female 
(n=1780) 
Age (years) 56.5·8.3 54.1·8.4 
Waist circumference (cm) 86.4·7.9 80.9·8.8 
Body Mass Index (kg/້) 24.4·3.4 24.6·3.4 
Cigarette smoking (n,%)   
Non smoker 396(33.9) 1737(97.7) 
Ex smoker 319(27.3) 10(0.6) 
Current smoker 452(38.7) 31(1.7) 
Alcohol consumption (n,%)   
No drinker 297(25.4) 1345(75.8) 
Ex drinker 82(7.0) 14(0.8) 
Current drinker 789(67.6) 415(23.4) 
Exercise (n,%)   
Yes 370(31.8) 553(31.2) 
No 793(68.2) 1222(68.8) 
Systolic Blood Pressure (mm/Hg) 131.8·17.3 128.4·17.7 
Diastolic Blood Pressure (mm/Hg) 85.0·15.8 81.5·11.7 
Total Cholesterol (mg/dL) 195.7·34.6 200.9·37.7 
Triglyceride (mg/dL) 167.7·122.9 129.5·79.0 
HDL-Cholesterol (mg/dL) 44.6·11.2 47.8·11.1 
Fasting Plasma Glucose (mg/dL) 99.9·23.7 93.9·18.4 
AST (IU/L) 30.2·16.6 24.5·8.7 
ALT (IU/L) 28.3·17.0 21.2·11.8 
GGT (IU/L) 55.6·93.5 20.4·25.6 
VFA (c້) 123.4·30.3 84.3·33.7 
Abbreviations: HDL, High-density lipoprotein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, Ȗ-
glutamyltransferase; VFA, visceral fat area. 
*Data are expressed as mean·SD unless otherwise indicated. 
G
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Table 2. Characteristics of the study population according to GGT levels in men  
Quartiles of GGT level (IU/L) 
୘20
(n=280) 
20.0-30.9 
(n=288) 
31.0-56.9 
(n=302) 
˻57
(n=298) 
P value
for trend 
Age(years) 57.7(8.3) 57.2(8.2) 56.3(7.8) 55.1(8.5) 0.000 
Waist circumference (cm) 83.2(7.6) 85.8(7.9) 88.1(7.6) 88.1(7.3) 0.000 
Body Mass Index (kg/້) 23.3(3.1) 24.5(4.2) 25.0(2.9) 24.7(3.0) 0.000 
Cigarette smoking (%)     0.000†
Non smoker 31.6 29.3 21.2 17.9  
Ex smoker 19.1 26.6 26.6 27.6  
Current smoker 20.8 19.2 29.4 30.5  
Alcohol consumption (%)     0.000†
No drinker 45.5 28.3 18.2 8.1  
Ex drinker 31.7 24.4 28.0 15.9  
Current drinker 15.1 23.3 28.5 33.1  
Exercise     0.363 
Yes 23.7 23.6 25.7 27.0  
No 24.6 26.8 26.2 22.4  
Systolic Blood Pressure (mm/Hg) 128.5(15.9) 131.0(17.0) 133.1(17.5) 134.3(18.0) 0.000 
Diastolic Blood Pressure (mm/Hg) 83.0(10.9) 83.2(10.6) 86.8(24.1) 86.6(12.2) 0.000 
Total Cholesterol (mg/dL) 185.8(32.2) 196.3(31.7) 200.5(32.4) 199.5(39.7) 0.000 
Triglyceride (mg/dL) 114.4(66.9) 146.9(106.6) 179.6(106.9) 225.9(161.1) 0.000 
HDL- Cholesterol (mg/dL) 42.9(9.8) 44.6(10.5) 44.2(10.6) 46.8(13.4) 0.000 
AST (IU/L) 24.3(5.9) 26.1(6.5) 29.1(8.5) 40.7(27.9) 0.000 
ALT (IU/L) 20.1(6.7) 23.9(10.0) 29.0(13.2) 39.4(24.9) 0.000 
Fasting Plasma Glucose (mg/dL) 97.4(24.3) 96.9(19.5) 101.8(25.8) 103.4(23.9) 0.000 
VFA (c້) 112.3(29.6) 121.4(27.5) 131.8(32.3) 127.3(28.2) 0.000 
Abbreviations: GGT, Ȗ-glutamyltransferase; HDL, High-density lipoprotein; AST, aspartate aminotransferase; ALT, alanine 
aminotransfease; VFA, visceral fat area. 
*Data are expressed as mean (SD) unless otherwise indicated. 
†P value
G
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Table 3. Characteristics of the study population according to GGT levels in women 
Quartiles of GGT level (IU/L) 
୘11
(n=417) 
11.0-14.9 
(n=432) 
15.0-21.9 
(n=463) 
˻22
(n=468) 
P value 
for trend 
Age(years) 51.6(8.1) 53.9(8.5) 55.0(8.3) 55.5(8.1) 0.000 
Waist circumference (cm) 77.3(7.7) 79.7(8.5) 81.9(8.6) 84.3(8.8) 0.000 
Body Mass Index (kg/້) 23.5(2.8) 24.2(3.0) 24.9(3.2) 25.7(4.0) 0.000 
Cigarette smoking (%)     0.000†
Non smoker 23.8 24.4 26.1 25.7  
Ex smoker 10.0 30.0 20.0 40.0  
Current smoker 9.7 16.1 22.6 51.6  
Alcohol consumption (%)     0.000†
No drinker 25.0 24.8 27.1 23.1  
Ex drinker 21.4 28.6 21.4 28.6  
Current drinker 18.3 22.4 22.9 36.4  
Exercise     0.355 
Yes 22.3 24.4 26.9 26.4  
No 25.9 24.1 24.1 26.0  
Systolic Blood Pressure (mm/Hg) 124.7(16.3) 129.5(17.6) 130.1(17.8) 132.0(17.9) 0.000 
Diastolic Blood Pressure (mm/Hg) 79.1(10.6) 80.4(12.3) 82.5(11.5) 83.6(11.7) 0.000 
Total Cholesterol (mg/dL) 186.7(32.0) 197.2(33.2) 203.9(36.3) 214.1(42.5) 0.000 
Triglyceride (mg/dL) 99.9(49.9) 113.4(53.7) 141.0(85.2) 159.4(98.3) 0.000 
HDL- Cholesterol (mg/dL) 48.2(11.4) 47.9(10.8) 47.0(10.3) 48.3(11.6) 0.851 
AST (IU/L) 22.0(5.1) 22.6(5.0) 23.6(5.5) 28.2(13.3) 0.000 
ALT (IU/L) 16.2(5.9) 17.8(6.5) 20.7(7.6) 29.2(17.6) 0.000 
Fasting Plasma Glucose (mg/dL) 89.1(11.7) 91.2(12.8) 94.3(17.7) 100.2(25.1) 0.000 
VFA (c້) 69.4(27.6) 79.1(30.0) 88.1(33.6) 98.8(35.6) 0.000 
Abbreviations: GGT, Ȗ-glutamyltransferase; HDL, High-density lipoprotein; AST, aspartate aminotransferase; ALT, alanine 
aminotransferase; VFA, visceral fat area. 
*Data are expressed as mean (SD) unless otherwise indicated. 
†P value
G
G
G
G
G
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Risk of waist circumference, visceral fat area, and Ȗ-
glutamyltransferase on prevalence of diabetes 
The multivariate adjusted odds ratios (95% CI) of prevalence of diabetes in each quartile of WC were 
1.83(1.19-28.2), 2.30(1.50-3.52), 3.44(2.27-5.21), when compared with the reference category. The 
corresponding adjusted odds ratio (95% CI) of prevalence of diabetes across VFA quartiles were 1.00, 
1.16(0.77-1.74), 1.92(1.28-3.37), 2.23(1.48-3.37). The corresponding adjusted odds ratio (95% CI) of 
prevalence of diabetes according to GGT quartiles were 1.00, 1.25(0.82-1.92), 2.23(1.50-3.32), 3.81(2.50-
5.79), respectively (Table 4).  
Table 4 also shows the risk of prevalence of diabetes according to WC, VFA, and GGT after 
stratification by alcohol consumption. When non-drinker was defined as a non-drinker or ex-drinker, it 
was found that for the non-drinking group and current drinking group, the adjusted odds ratio showed an  
increased response to successive quartiles of WC, VFA, and GGT.  
In Figure 1, area under the curve (AUC) for GGT using the receiver-operating characteristics (ROC) 
curve was 0.65 (p <0.001). Using the same method, the AUC for WC and VFA were 0.65 (p <0.001) and 
0.63 (p <0.001), respectively.  
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Table 4. Adjusted odds ratio (ORs) and 95% CI for prevalence of diabetes by Category of WC, 
VFA or GGT according to alcohol consumption.
OR(95.5% CI) 
Total Non-Drinker Current Drinker 
Waist circumference, cm  
୘77 1.0 1.0 1.0 
77-82.9 1.83(1.19-28.2) 2.20(1.26-3.85) 1.30(0.6-2.51) 
83-88.9 2.30(1.50-3.52) 2.61(1.48-4.61) 1.84(0.97-3.50) 
89 3.44(2.27-5.21) 3.94(2.26-6.86) 2.72(1.45-5.10) 
Visceral fat area, c້
୘71 1.0 1.0 1.0 
71-99.9 1.16(0.77-1.74) 1.09(0.68-1.77) 1.23(0.56-2.69) 
100.0-121.9 1.92(1.28-3.37) 2.29(1.41-3.73) 1.62(0.76-3.43) 
122 2.23(1.48-3.37) 1.96(1.16-3.30) 2.34(1.10-4.99) 
Ȗ-glutamyltransferase, IU/L 
୘13.0 1.0 1.0 1.0 
13-18.9 1.25(0.82-1.92) 1.33(0.82-2.15) 1.05(0.41-2.67) 
19-32.9 2.23(1.50-3.32) 2.44(1.53-3.88) 1.92(0.86-4.38) 
33 3.81(2.50-5.79) 3.23(1.86-5.57) 3.84(1.72-8.59) 
*Adjusted for age, sex, cigarette smoking, alcohol consumption, exercise, systolic blood pressure, and total cholesterol. 
† Non-drinker is defined as Non-drinker plus Ex-drinker.
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Figure 1. ROC (receiver-operating characteristics) curve of VFA, WC and GGT associated with 
increase in the prevalence of type 2 diabetes.  
Abbreviations: GGT, Ȗ-glutamyltransferase; VFA, visceral fat area; WC, waist circumference; AUC, area under the curve. 
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Combined effect of waist circumference, visceral fat area, and Ȗ-
glutamyltransferase on prevalence of diabetes 
We explored patterns of effect modification among WC, VFA and GGT using multiple logistic 
analyses. Table 5 shows adjusted odds ratio estimated for the strata defined by pairs of three variables: 
GGT, VFA, and WC. For GGT and VFA, the pattern of odds ratio estimates suggested a possibly additive 
effect. The interaction between GGT and WC was also possibly additive.  
G X^
Table 5. Adjusted odds ratio (ORs) and 95% CI of prevalent diabetes 
Variable1 Variable2 No OR (95% CI) 
GGT, IU/L VFA, c້
୘19 ୘100 48 1.0 
୘19 100 50 2.01(1.30-3.11) 
19 ୘100 61 2.68(1.78-4.05) 
19 100 190 3.88(2.63-5.74) 
GGT, IU/L WC, cm   
୘19 ୘83 41 1.0 
୘19 83 57 2.24(1.46-3.44) 
19 ୘83 64 2.82(1.84-4.32) 
19 83 187 4.17(2.83-6.15) 
Abbreviations: GGT, Ȗ-glutamyltransferase; VFA, visceral fat area; WC, waist circumference. 
*Adjusted for age, sex, cigarette smoking, alcohol consumption, exercise, systolic blood pressure, and total cholesterol. 
G X_
Interaction among waist circumference, visceral fat area, BMI and 
serum GGT on the risk for prevalence of diabetes 
Fig 2 shows multivariate adjusted odds ratio (ORs) and 95% CI for prevalence of diabetes by category 
of WC and quartiles of serum GGT. Within the lowest quartile of GGT, WC was not associated with 
prevalence of diabetes, in contrast to the higher quartiles of serum GGT, risk for prevalence of diabetes 
increased for successive quartiles of WC. But, the interaction between WC and serum GGT on the risk for 
prevalence of diabetes was not significant. In Fig 3, adjusted odds ratio (ORs) and 95% CI of prevalent 
diabetes by category of VFA and quartiles of serum GGT are presented similarly to Fig 2. Such as the 
association between WC and risk of prevalent diabetes, ORs of VFA on the risk of prevalence of diabetes 
were not increased within the lower quartiles of GGT. However, independent of quartiles of VFA, risk for 
prevalence of diabetes was increased according to quartiles of serum GGT. The associations among BMI, 
serum GGT, and prevalence of diabetes were similar to Fig 2 and 3 (Fig 4). The interactions of VFA and 
BMI to serum GGT were not significant, either.  
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Figure2. Interaction between WC and serum GGT on the risk for prevalence of type 2 diabetes 
among men and women. Adjusted for age, sex, cigarette smoking, alcohol consumption, exercise, 
systolic blood pressure, and total cholesterol.  
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Figure 3. Interaction between VFA and serum GGT on the risk for prevalence of type 2 diabetes 
among men and women. Adjusted for age, sex, cigarette smoking, alcohol consumption, exercise, 
systolic blood pressure, and total cholesterol. 
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Figure 4. Interaction between BMI and serum GGT on the risk for prevalence of type 2 diabetes 
among men and women. Adjusted for age, sex, cigarette smoking, alcohol consumption, exercise, 
systolic blood pressure, and total cholesterol. 
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DISCUSSION 
In this cross-sectional study, we found that higher levels of WC and VFA were directly associated with 
an increased risk of type 2 diabetes. Serum GGT activity was also positively associated with the 
prevalence of diabetes. However, the association between various parameters of abdominal obesity and 
the prevalence of diabetes was not clear after stratification by serum GGT. On the contrary, as WC or 
VFA increased, the association between serum GGT and prevalence of diabetes was strengthened. No 
interaction among these three risk factors was observed statistically. 
In previous prospective cohort studies, the association of BMI with incidence of diabetes was stronger 
among participants with high normal GGT compared to those with low normal GGT (Lee et al, 2003; Lee 
et al, 2004). In a recent cross-sectional study, the association of obesity with the prevalence for type 2 
diabetes found that serum GGT activity was also increased in participants with high normal range of GGT, 
but not with low normal serum GGT activity (Lim et al, 2007). However, in our study, after stratified by 
quartiles of serum GGT, the association between BMI and the prevalence of type 2 diabetes was not 
significant in all categories of serum GGT. Yet, the association between GGT and prevalent diabetes was 
presented in each group of BMI after stratified by quartiles of BMI. 
Despite of the well-known complications of obesity (Bray et al, 1985), some very obese patients do 
not have fairly normal metabolic risk factors despite of their significant obesity. On the other hand, some 
moderately overweight patients are characterized by a metabolic cluster of diabetogenic and atherogenic 
abnormalities. Thus, recently, many studies have demonstrated that the distribution of visceral adipose 
tissue was correlated with metabolic risk factors such as reduced HDL particle size (Pascot et al, 2001), 
glucose tolerance and plasma insulin (Pouliot et al, 1992), plasma lipoprotein levels and hyperinsulinemia 
(Tchernof et al, 1996), and elevated C-reactive protein (Lemieux et al, 2001) that predictive of an 
increased risk for the development of type 2 diabetes and cardiovascular disease. Therefore, in particular, 
the association of WC or VFA with the prevalence of diabetes according to serum GGT was analyzed in 
this study.  
An increase of serum GGT activity is conventionally known as a marker of alcohol abuse and /or liver 
damage (Teschke et al, 1977). However, other studies involving several ethnic groups have reported that 
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serum concentration of GGT, even within its normal range, is an independent risk factor for the 
development of diabetes (Perry et al, 1998; Lee et al, 2003, Lee et al, 2003, Nakanishi et al, 2004). Perry 
et al. (Perry et al, 1998) speculated that visceral adipose tissue could play a role in the association of GGT 
with type 2 diabetes. The same authors also interpreted GGT as a marker of hepatic steatosis and hepatic 
insulin resistance associated with diabetic pathogenesis (Perry et al, 1998). Recently, Iwasaki et al. 
reported serum level of GGT was associated with visceral adiposity independent of hepatic fat content 
(Iwasaki et al, 2008). Our data presented a trend in which neither WC nor VFA were not associated with 
prevalence of diabetes after stratification by serum GGT not only within the low normal range of GGT 
but also at higher levels of GGT. In contrast to this finding, serum GGT was positively associated with 
prevalence of diabetes in each group of quartiles of WC or VFA.   
This interaction between WC or VFA and serum GGT on the risk of prevalence of diabetes was not 
statistically significant (p for interaction=0.22, 0.34) and different from the interaction between BMI and 
GGT on type 2 diabetes found in a previous study (Lim et al, 2007). In spite of that, this finding suggests 
that serum GGT may be more influential on the risk of diabetes than abdominal obesity or visceral 
adiposity. That is visceral fat can be considered as a risk factor for diabetes, and it is strengthened when it 
is combined with other risk factors such as increased GGT.  
The mechanisms associated with the interaction of serum GGT and visceral fat on risk for diabetes 
remain unclear. Some experimental studies have reported that GGT plays a pivotal role in maintenance of 
antioxidant defense (Takanashi et al, 1997; Karp et al, 2001). Increase of GGT activity is a response to 
oxidative stress, facilitating reutilization of glutathione. Another study indicated that GGT was involved 
directly in the generation of reactive oxygen species (ROS) in the presence of Fe3+ (Drozdz et al, 1998). 
Serum GGT was positively associated with F2-isoprotanes and C-reactive protein (Lee et al, 2003) and 
inversely associated with serum antioxidant level (Lee et al, 2004).  
In recent studies, some investigators reported a dose-response relation between serum concentrations 
of persistent organic pollutants (POPs), which are a kind of endocrine disruptor, and prevalence of 
diabetes (Lee et al, 2006). The same authors demonstrated that the association between obesity and 
diabetes became clearer when serum concentrations of POPs were increased, and also presented the 
positive association of POPs with serum GGT. They explained that POPs was associated with serum GGT 
because GGT is a marker of glutathione conjugation and synthesis and hypothesized that POPs stored in 
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fat tissue might be more important than obesity itself to explain the pathogenesis of type 2 diabetes (Lee 
et al, 2008). 
This association between serum concentrations of POPs and obesity and the interaction between POPs 
and obesity on the risk of type 2 diabetes at least partially may explain the results of present study. 
Our study has several limitations to take into consideration. First, it was a cross-sectional design, 
suggesting that caution should be used in causal interpretations. However, because similar findings were 
shown in previous observational studies, even though the independent variables were different, these 
results supports the conclusion that serum GGT has a stronger impact on the risk of diabetes than visceral 
fat or WC. 
Second, VFA, as an indicator of visceral adipose tissue, was measured by BIA. Though BIA 
measurement has many practical advantages (eg. inexpensive, simple technique, noninvasive, available), 
the validity and reliability of BIA is not as excellent as those of CT scans to estimate visceral adipose 
tissue. Therefore, to overcome this disadvantage, we compared the results of VFA analyzed by BIA to 
those of VFA measured by CT scan. Although the study size was small, in this preliminary study, the 
results of BIA well correlated with those of CT scans. We also used the interaction between WC and 
serum GGT on the prevalence of diabetes to compare to that of VFA. 
In summary, our findings revealed a combined effect of WC or VFA and serum GGT on the risk of 
prevalence of diabetes. These results indicate that serum GGT may be a more influential factor than 
abdominal obesity or visceral fat on the risk of prevalence of diabetes. Accordingly, in clinical settings, 
the association between WC or VFA, even though it is measured by BIA, and serum GGT may be 
practical to evaluate the risk of diabetes.  
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